Increased Rheumatoid Factor production in patients with severe COVID-19
Diagnostic Microbiology and Infectious Disease(2024)
Abstract
Background
Searching for Rheumatoid Factors (RF) in patients with coronavirus disease (COVID-19) has rarely been described.
Objectives
To investigate the association between RF isotypes (IgM, IgA, and IgG) and different clinical presentations of COVID-19 in a series of Tunisian patients.
Study design
Eighty-two COVID-19 patients were enrolled in this study. Symptomatic cases were recruited from the Department of COVID-19 and the intensive care unit (ICU) of the University Hospital of Mahdia, Tunisia, from January 2021 to March 2021. Different RF isotypes were assessed using a commercial enzyme-linked immunosorbent assay (ELISA).
Results
Forty-one patients (50%) had RF of any isotype. Thirty-two patients (39%) were tested positive for RF-IgM. Symptomatic forms of the disease were associated with RF-IgM positivity (p = 0.005). The mean concentration of RF-IgM was higher in the severe form than in the moderate and asymptomatic forms (p = 0.006).
Conclusions
Our study suggests that the production of RF-IgM isotype is increased in patients with severe COVID-19.
MoreTranslated text
Key words
Covid-19,rheumatoid factor,infection,viruses
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined